Jan N.
- Country
- Czechia
- Department
- Opthalmology
Research Overview
- Randomized, Double-Masked, Multicenter Phase 2/3 Trial of Intravitreal MK-8748 Versus Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration
- Phase III Randomized Double‑Masked Placebo‑Controlled Study of Subcutaneous Satralizumab in Adults with Moderate‑to‑Severe Thyroid Eye Disease
- Phase 3 Multicenter Randomized Double-Masked Placebo-Controlled Trial of Tinlarebant in Geographic Atrophy Treatment
Data & Insights
Has run more than one trial at 97 of 219 partner sites.
Specializations
Ophthalmology and Retinal Therapeutics
The investigator concentrates on diseases of the posterior segment, emphasizing vascular retinal conditions and degenerative processes.
- Diabetic macular edema
- Neovascular age‑related macular degeneration
- Geographic atrophy
- Macular edema secondary to retinal vein occlusion
- Wet age‑related macular degeneration
Collaborations aim to integrate novel biologics and gene‑editing strategies for vision preservation.
Hematologic Malignancies and Bone Marrow Failure
Focuses on malignant and non‑malignant disorders of the blood and marrow, targeting therapeutic avenues in leukemias, lymphomas, and myelodysplastic syndromes.
- Acute myeloid leukemia
- Chronic lymphocytic leukemia
- Diffuse large B‑cell lymphoma
- Multiple myeloma
- High‑risk myelodysplastic syndrome
Research integrates targeted inhibitors and cellular immunotherapies to improve remission durability.
Cardiovascular Disease and Metabolic Disorders
Engages in therapeutic development for atherosclerotic disease, heart failure, hypertension, and metabolic liver disease.
- Acute coronary syndrome
- Chronic heart failure with reduced ejection fraction
- Resistant hypertension
- Non‑alcoholic steatohepatitis
- Aortic valve disease
Efforts emphasize biomarker‑driven risk stratification and combination drug regimens.
Neurology and Neurodegenerative Disorders
Addresses disorders of the central and peripheral nervous system, with emphasis on stroke, epilepsy, and demyelinating disease.
- Acute ischemic stroke
- Chronic migraine
- Multiple sclerosis
- Refractory status epilepticus
- Cognitive impairment due to Alzheimer’s disease
Clinical programs explore neuroprotective agents and disease‑modifying immunotherapies.
Autoimmune and Inflammatory Conditions
Investigates immune‑mediated pathologies, targeting B‑cell dysregulation and systemic vasculitis.
- ANCA‑associated vasculitis
- Primary immune thrombocytopenia
- Hidradenitis suppurativa
- Atopic dermatitis
- Generalized myasthenia gravis
Trials evaluate biologic modulators that recalibrate aberrant immune signaling.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.